Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia

High-Affinity Small-Molecule Inhibitors of the Menin-Mixed Lineage Leukemia (MLL) Interaction Closely Mimic a Natural Protein–Protein Interaction

Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia

A Box of Chemistry to Inhibit the MEN1 Tumor Suppressor Gene Promoting Leukemia - Ozyerli‐Goknar - 2021 - ChemMedChem - Wiley Online Library

Challenges and opportunities in targeting the menin-MLL interaction.

Frontiers MLL-Rearranged Leukemias—An Update on Science and Clinical Approaches

Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia

Children, Free Full-Text

Frontiers Molecular Approaches to Treating Pediatric Leukemias

Challenges and opportunities in targeting the menin-MLL interaction.

Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia

Covalent and noncovalent constraints yield a figure eight-like conformation of a peptide inhibiting the menin-MLL interaction - ScienceDirect

A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia - ScienceDirect

A novel Menin-MLL1 inhibitor, DS-1594a, prevents the progression of acute leukemia with rearranged MLL1 or mutated NPM1, Cancer Cell International